Copyright Reports & Markets. All rights reserved.

Global and Japan Biomonitoring and Bioburden Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Culture Media and Reagents Kit
    • 1.2.3 Instruments
    • 1.2.4 PCR (Polymerase Chain Reaction)
    • 1.2.5 Automated Microbial Identification Systems
    • 1.2.6 Microscope
    • 1.2.7 Others
  • 1.3 Market by Application
    • 1.3.1 Global Biomonitoring and Bioburden Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Medical Devices Testing
    • 1.3.3 Monitoring of Manufacturing Process
    • 1.3.4 Environmental Monitoring
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biomonitoring and Bioburden Testing Market Perspective (2015-2026)
  • 2.2 Global Biomonitoring and Bioburden Testing Growth Trends by Regions
    • 2.2.1 Biomonitoring and Bioburden Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biomonitoring and Bioburden Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biomonitoring and Bioburden Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biomonitoring and Bioburden Testing Players by Market Size
    • 3.1.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Biomonitoring and Bioburden Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Biomonitoring and Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue
  • 3.4 Global Biomonitoring and Bioburden Testing Market Concentration Ratio
    • 3.4.1 Global Biomonitoring and Bioburden Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biomonitoring and Bioburden Testing Revenue in 2019
  • 3.5 Key Players Biomonitoring and Bioburden Testing Area Served
  • 3.6 Key Players Biomonitoring and Bioburden Testing Product Solution and Service
  • 3.7 Date of Enter into Biomonitoring and Bioburden Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biomonitoring and Bioburden Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2021-2026)

5 Biomonitoring and Bioburden Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biomonitoring and Bioburden Testing Market Size (2015-2026)
  • 6.2 North America Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
  • 6.3 North America Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
  • 6.4 North America Biomonitoring and Bioburden Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Biomonitoring and Bioburden Testing Market Size (2015-2026)
  • 7.2 Europe Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
  • 7.3 Europe Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
  • 7.4 Europe Biomonitoring and Bioburden Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Biomonitoring and Bioburden Testing Market Size (2015-2026)
  • 8.2 China Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
  • 8.3 China Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
  • 8.4 China Biomonitoring and Bioburden Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Biomonitoring and Bioburden Testing Market Size (2015-2026)
  • 9.2 Japan Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
  • 9.3 Japan Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
  • 9.4 Japan Biomonitoring and Bioburden Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Biomonitoring and Bioburden Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Biomonitoring and Bioburden Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Merck
    • 11.1.1 Merck Company Details
    • 11.1.2 Merck Business Overview
    • 11.1.3 Merck Biomonitoring and Bioburden Testing Introduction
    • 11.1.4 Merck Revenue in Biomonitoring and Bioburden Testing Business (2015-2020))
    • 11.1.5 Merck Recent Development
  • 11.2 STERIS Laboratories
    • 11.2.1 STERIS Laboratories Company Details
    • 11.2.2 STERIS Laboratories Business Overview
    • 11.2.3 STERIS Laboratories Biomonitoring and Bioburden Testing Introduction
    • 11.2.4 STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.2.5 STERIS Laboratories Recent Development
  • 11.3 Charles River Laboratories International
    • 11.3.1 Charles River Laboratories International Company Details
    • 11.3.2 Charles River Laboratories International Business Overview
    • 11.3.3 Charles River Laboratories International Biomonitoring and Bioburden Testing Introduction
    • 11.3.4 Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.3.5 Charles River Laboratories International Recent Development
  • 11.4 Lumex Instruments
    • 11.4.1 Lumex Instruments Company Details
    • 11.4.2 Lumex Instruments Business Overview
    • 11.4.3 Lumex Instruments Biomonitoring and Bioburden Testing Introduction
    • 11.4.4 Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.4.5 Lumex Instruments Recent Development
  • 11.5 Pacific BioLabs
    • 11.5.1 Pacific BioLabs Company Details
    • 11.5.2 Pacific BioLabs Business Overview
    • 11.5.3 Pacific BioLabs Biomonitoring and Bioburden Testing Introduction
    • 11.5.4 Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.5.5 Pacific BioLabs Recent Development
  • 11.6 Sigma-Aldrich
    • 11.6.1 Sigma-Aldrich Company Details
    • 11.6.2 Sigma-Aldrich Business Overview
    • 11.6.3 Sigma-Aldrich Biomonitoring and Bioburden Testing Introduction
    • 11.6.4 Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.6.5 Sigma-Aldrich Recent Development
  • 11.7 WuXi AppTec
    • 11.7.1 WuXi AppTec Company Details
    • 11.7.2 WuXi AppTec Business Overview
    • 11.7.3 WuXi AppTec Biomonitoring and Bioburden Testing Introduction
    • 11.7.4 WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.7.5 WuXi AppTec Recent Development
  • 11.8 Dynatec Labs
    • 11.8.1 Dynatec Labs Company Details
    • 11.8.2 Dynatec Labs Business Overview
    • 11.8.3 Dynatec Labs Biomonitoring and Bioburden Testing Introduction
    • 11.8.4 Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.8.5 Dynatec Labs Recent Development
  • 11.9 Nelson Laboratories
    • 11.9.1 Nelson Laboratories Company Details
    • 11.9.2 Nelson Laboratories Business Overview
    • 11.9.3 Nelson Laboratories Biomonitoring and Bioburden Testing Introduction
    • 11.9.4 Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
    • 11.9.5 Nelson Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biomonitoring and Bioburden Testing Scope and Market Size
    Biomonitoring and Bioburden Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biomonitoring and Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Culture Media and Reagents Kit
    Instruments
    PCR (Polymerase Chain Reaction)
    Automated Microbial Identification Systems
    Microscope
    Others

    Market segment by Application, split into
    Medical Devices Testing
    Monitoring of Manufacturing Process
    Environmental Monitoring

    Based on regional and country-level analysis, the Biomonitoring and Bioburden Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Biomonitoring and Bioburden Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Merck
    STERIS Laboratories
    Charles River Laboratories International
    Lumex Instruments
    Pacific BioLabs
    Sigma-Aldrich
    WuXi AppTec
    Dynatec Labs
    Nelson Laboratories

    Buy now